GFP-expressing CRC cells were cultured with human peritoneum and treated with either the pan-MMP inhibitor batimastat or the specific MMP2/9 inhibitor III immediately after seeding onto the peritoneum. The gene discussed is MMP2; the disease is colorectal carcinoma.